Tag: biomedical
-

Challenge Seeks Tech, Models to Reduce Stillbirths
A research competition is seeking better technologies to measure gestational development and predict outcomes to reduce the number of stillbirths by half.
-

GSK Acquires Advanced Vaccine Biotech in $3.3B Deal
Drug maker GSK is buying a biotechnology company developing vaccines for respiratory and infectious diseases that generate multiple immune responses.
-

Grant Funds Epilepsy Stem Cell Therapy Trial
A developer of stem cell therapies for neurological disorders is receiving an $8 million grant to advance a treatment for a common type of epilepsy.
-

Biobank Study to Assess Obesity Types, Genetics
A study is now enrolling individuals to better understand different types of obesity, as well as genetics and other factors behind various obesity conditions.
-

High Speed Genetics Tech Start-Up Raises $15M
A start-up enterprise developing a high-performance genomic screening and detection technology is raising $15 million in early financing.
-

AI Drug Company Creating Covid-19 Therapy for Rapid Delivery
A company applying artificial intelligence to drug discovery says it designed a new oral drug for Covid-19 infections that can be quickly produced.
-

Trial Shows Therapy Controls Gut Disorder with Healthy Microbes
Results from a clinical trial show a microbiome treatment produces healthy gut microbes that reduce recurrences of C. difficile infections.
-

Addiction Therapy, VR Companies Partner on Veteran PTSD
A developer of addiction therapies and virtual reality software company are collaborating on help for veterans suffering from post-traumatic stress disorder.
-

Venture Investor Funds Cell Therapy Targeting Tech
A venture capital company is funding biomedical engineering research to improve the reach and targeting of cell therapies to more diseases.
-

Precision Antibacterial Company Raises $35M in New Funds
A biotechnology company creating targeted antibacterial and microbiome treatments aided by gene editing is raising $35 million in new venture funds.